US Stock MarketDetailed Quotes

RPRX Royalty Pharma

Watchlist
  • 28.470
  • +0.330+1.17%
Close Jul 22 16:00 ET
  • 28.580
  • +0.110+0.39%
Post 19:51 ET
12.84BMarket Cap15.99P/E (TTM)

Royalty Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Royalty Pharma Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

May 9, 2024

Revenue(YoY)

567.98M

-16.96%
EPS(YoY)

0.01

-98.68%
Analyst Rating

Strong Buy

Jul 11, 2024

Royalty Pharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 712.328M--
Aug 8, 20242024/Q2-- / 645.290M--
May 9, 20242024/Q1568.000M / 709.445M--
Feb 15, 20242023/Q4596.000M / 674.541M--
Nov 8, 20232023/Q3536.313M / 618.492M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 712.328M--
Aug 8, 20242024/Q2-- / 645.290M--
May 9, 20242024/Q1568.000M / 709.445M--
Feb 15, 20242023/Q4596.000M / 674.541M--
Nov 8, 20232023/Q3536.313M / 618.492M--

Unlock Free Earnings Estimates

Royalty Pharma Earnings Reports

  • Royalty Pharma | 10-Q: Quarterly report

    May 9 09:10 ET

  • Royalty Pharma | 10-K: Annual report

    Feb 15 09:12 ET

  • Royalty Pharma: Q3 2023 Earnings Report

    Nov 8, 2023 09:04 ET

  • Royalty Pharma | 10-Q: Q2 2023 Earnings Report

    Aug 8, 2023 09:03 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 11, 2024

    Strong Buy

    • Buy

      83.33%

    • Hold

      16.67%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg